These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29100440)

  • 1. Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis.
    Chen Z; Zheng Y; Ji G; Liu X; Li P; Cai L; Guo Y; Yang J
    Oncotarget; 2017 Sep; 8(44):77975-77989. PubMed ID: 29100440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
    Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
    Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.
    Yang L; Tan Y; Dan H; Hu L; Zhang J
    Acta Radiol; 2021 Sep; 62(9):1238-1247. PubMed ID: 32903025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.
    Alabousi M; Salameh JP; Gusenbauer K; Samoilov L; Jafri A; Yu H; Alabousi A
    BJU Int; 2019 Aug; 124(2):209-220. PubMed ID: 30929292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
    Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
    Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis.
    Haghighi M; Shah S; Taneja SS; Rosenkrantz AB
    J Comput Assist Tomogr; 2013; 37(6):980-8. PubMed ID: 24270122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis.
    Zeng J; Cheng Q; Zhang D; Fan M; Shi C; Luo L
    Front Oncol; 2021; 11():620628. PubMed ID: 33680965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.
    Schimmöller L; Quentin M; Arsov C; Hiester A; Buchbender C; Rabenalt R; Albers P; Antoch G; Blondin D
    Eur Radiol; 2014 Oct; 24(10):2582-9. PubMed ID: 24972954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
    Wu LM; Xu JR; Gu HY; Hua J; Zhu J; Chen J; Zhang W; Hu J
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):252-64. PubMed ID: 23313568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
    Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
    Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
    Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis.
    Bi Q; Chen Y; Chen J; Zhang H; Lei Y; Yang J; Zhang Y; Bi G
    Clin Imaging; 2021 Oct; 78():206-213. PubMed ID: 34049140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.
    Bass EJ; Pantovic A; Connor M; Gabe R; Padhani AR; Rockall A; Sokhi H; Tam H; Winkler M; Ahmed HU
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):596-611. PubMed ID: 33219368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
    Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
    Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dynamic contrast enhancement on transition zone prostate cancer in Prostate Imaging Reporting and Data System Version 2.1.
    Zhang J; Xu L; Zhang G; Zhang X; Bai X; Sun H; Jin Z
    Radiol Oncol; 2023 Mar; 57(1):42-50. PubMed ID: 36655324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis.
    Zong R; Ma X; Shi Y; Geng L
    Br J Radiol; 2023 Oct; 96(1150):20230239. PubMed ID: 37660472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
    Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
    NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
    Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
    Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection.
    Gholizadeh N; Greer PB; Simpson J; Goodwin J; Fu C; Lau P; Siddique S; Heerschap A; Ramadan S
    J Biomed Sci; 2021 Jul; 28(1):54. PubMed ID: 34281540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.